National / Science & Health Feb 16, 2021
The season presents an added challenge amid the pandemic as rubbing itchy eyes and wiping runny noses threaten to boost the risk of viral infection.
The season presents an added challenge amid the pandemic as rubbing itchy eyes and wiping runny noses threaten to boost the risk of viral infection.
WHO approval of AstraZeneca-Oxford vaccine widens access in developing world
The WHO's review found that the vaccine met the "must-have" criteria for safety and that its efficacy benefits outweighed its risks.
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says
The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.
Doctors' and nurses' groups in Japan declare medical emergency
In a statement, nine groups called on the government to provide proper assistance to front-line medical workers, and on the public to take thorough steps to prevent infections.
Emmanuel Macron has the same problem as King Louis XVI
French orders of the Pfizer vaccine run to about 45 million, which means around 22 million people can receive the two-shot course.
Vaccines don’t mean we’ll see the last of COVID-19, experts warn
Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.
The coronavirus is mutating. What does that mean for us?
It will be very hard for the coronavirus to escape the body’s defenses, despite the many variations it may adopt.
South Korea sets record COVID-19 cases as prison reports major outbreak
With daily infections over 1,000 for a fifth consecutive day, some medical experts and politicians criticized the government for being too loose with social distancing rules.
Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan
Officials said the approval would be made "a top priority in the screening process" once the firm submits data from an ongoing clinical trial specific to Japan, expected in February.
Researchers found that people who participated in the government's Go To Travel campaign were as much as twice as likely to have COVID-19 symptoms than those who did not.
The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.
WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024
Documents show the program's promoters say it is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.